GE HealthCare is recalling malfunctioning TruSignal sensors that may reduce the amount of energy sent to the heart during defibrillation without any notification to the care provider
July 28, 2023
GE HealthCare Recalls TruSignal SpO2 Sensors for Issues That May Reduce Defibrillation Energy, Expose Patients to Unintended Voltage, or Give Inaccurate Readings
July 28, 2023 — GE HealthCare is recalling malfunctioning TruSignal sensors that may reduce the amount of energy sent…
Read More
Primary endpoints across three studies underscore the importance of accuracy, utility, and efficiency in coronary artery disease diagnostics and clinical decision making
July 28, 2023
HeartFlow to Announce New Data at SCCT23
July 28, 2023 — Respective results from the REVEALPLAQUE, DECODE, and SMART-CT clinical studies demonstrate the…
Read More
New calculator is based on precise statistical models from more than 8 million patients
July 28, 2023
The Society of Thoracic Surgeons Launches Next-generation Adult Cardiac Surgery Risk Calculator
July 28, 2023 — The Society of Thoracic Surgeons has launched its next-generation Operative Risk Calculator to assess…
Read More
Device manufacturers will be displaying their latest technologies at the 2023 Society of Cardiovascular Computed Tomography Annual Scientific Meeting (SCCT2023) being held in Boston from July 27 - 30.
July 28, 2023
Innovations in Photon Counting CT, AI to be Showcased at SCCT2023
Device manufacturers will be displaying their latest technologies at the 2023 Society of Cardiovascular Computed…
Read More
New AI guidance software will allow more medical professionals to conduct cardiac ultrasound in multiple care settings expanding patient access to cardiac imaging
July 27, 2023
FDA Grants Clearance for UltraSight’s AI-Powered Cardiac Ultrasound Technology
July 27, 2023 —UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial…
Read More
Abiomed is recalling the Impella Intravascular Left Sided Blood Pumps because the pump’s Instructions for Use (IFU) do not adequately address precautions to take when treating patients who have undergone transcatheter aortic valve replacement (TAVR)
July 27, 2023
Abiomed Recalls All Impella Left Sided Blood Pumps for Risk of Motor Damage After Contact with Transcatheter Aortic Valve Replacement (TAVR) Stent
July 27, 2023 — Abiomed is recalling the Impella Intravascular Left Sided Blood Pumps because the pump’s Instructions…
Read More
Abiomed is recalling the Impella Intravascular Left Sided Blood Pumps because the pump’s Instructions for Use (IFU) do not adequately address precautions to take when treating patients who have undergone transcatheter aortic valve replacement (TAVR)
July 27, 2023
MyoVista wavECG goes into clinical use at the Naya Imaging Center in Denmark
July 27, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-based medical…
Read More
Abbott is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air emboli to be introduced into patients who have procedures with this device.
July 26, 2023
Abbott Recalls Amplatzer Steerable Delivery Sheath for Increased Risk of Air Embolism
July 26, 2023 — Abbott is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air emboli to…
Read More
New U.S. patent provides intellectual property (IP) protection until December 2040, and may qualify for term extension beyond 2040
July 26, 2023
Tenax Therapeutics Issued U.S. Patent for Oral Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
July 26, 2023 — Tenax Therapeutics, Inc, a specialty pharmaceutical company focused on identifying, developing and…
Read More
Under the agreement, BIS will initiate the US commercialization activities for ŌNŌCOR’s ŌNŌ Retrieval Device.
July 26, 2023
ĹŚNĹŚCOR signs an exclusive US distribution agreement with B. Braun Interventional Systems
July 26, 2023 —ŌNŌCOR LLC, a medical technology company dedicated to developing essential safety tools and other…
Read More
HeartFlow announced that new data on HeartFlow Plaque Analysis and its RoadMap Analysis will be presented at the 2023 Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Boston, MA.
July 25, 2023
HeartFlow, Inc. to Announce New Data on Diagnosing and Managing Coronary Artery Disease at the 2023 Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting
July 25, 2023 — HeartFlow, Inc., the only non-invasive precision coronary care solution to provide both anatomic and…
Read More
Research shows that patients have better outcomes when they are treated at an accredited center, such as the Hypertension Center in the Smidt Heart Institute, by physicians specialized in the disease. Photo by Getty.
July 25, 2023
Smidt Heart Institute’s Hypertension Center Earns Accreditation
July 25, 2023 — The Hypertension Center in the Smidt Heart Institute at Cedars-Sinai has earned accreditation from the…
Read More
A multi-institutional team of scientists led by Dr. Mario Gaudino, the Stephen and Suzanne Weiss Professor in Cardiothoracic Surgery and assistant dean for clinical trials at Weill Cornell Medicine, has been approved for a nearly $30 million funding award from the Patient-Centered Outcomes Research Institute (PCORI).
July 25, 2023
Large PCORI Award Funds Study of Surgical Options for Coronary Artery Disease in Underrepresented Patient Populations
July 25, 2023 — A multi-institutional team of scientists led by Dr. Mario Gaudino, the Stephen and Suzanne Weiss…
Read More
With Only 21 Facilities Achieving this Award Nationally, AGH Ranks Among the Most Elite Mitral Valve Programs in the Country and Only Designated Center in Pennsylvania
July 24, 2023
Allegheny General Hospital Receives Recognition as a Mitral Valve Repair Reference Center from the American Heart Association and the Mitral Foundation
July 24, 2023 — Allegheny General Hospital (AGH), the flagship academic medical center of Allegheny Health Network (AHN…
Read More
BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, announced that the independent Data Safety Monitoring Board (DSMB) has completed its prespecified data review for the ongoing Phase III pivotal CardiAMP Cell Therapy Heart Failure Trial
July 24, 2023
BioCardia Announces DSMB Recommendation to Pause New Enrollment in Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial While Additional Blinded Data is Collected
July 24, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of…
Read More
SmartfIRE study is evaluating THERMOCOOL SMARTTOUCH SF Dual Energy Catheter’s potential to enable safe and simple procedures with the ability to deliver both radiofrequency (RF) and pulsed field ablation (PFA)
July 21, 2023
Biosense Webster Completes Enrollment in Pivotal Trial Evaluating PFA and RF Dual Energy Catheter for Patients with Atrial Fibrillation in Europe
July 21, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson &…
Read More
Pilot study will assess positive impacts of real-time safety monitoring on patient outcomes and treatment experience
July 21, 2023
AliveCor and Thomas Jefferson University Hospital Partner to Evaluate KardiaMobile 6L for QT Prolongation Screening in Patients Treated for Opioid Use Disorder
July 21, 2023 — AliveCor, a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today…
Read More
Pilot study will assess positive impacts of real-time safety monitoring on patient outcomes and treatment experience
July 21, 2023
Onecrea Medical Announces the Successful Completion of the First-in-human Implants of its Crea Aortic Valve
July 21, 2023 — Onecrea Medical has announced the success of the first-in-human implants of its Transcatheter Aortic…
Read More
The ACC Board of Trustees (BOT) has approved the College's newest officers and trustees who will assume their roles in April 2024 following ACC.24 in Atlanta, Ga.
July 20, 2023
ACC Announces New 2024 Officers, Trustees
July 20, 2023 — The ACC Board of Trustees (BOT) has approved the College's newest officers and trustees who will assume…
Read More
BicĂŞtre Hospital in Paris, France, and Baptist Stroke & Cerebrovascular Center in Jacksonville, Florida, USA, join global network of leading stroke centers as part of WE-TRUST multicenter clinical trial to evaluate the potential benefits of a Direct to Angio Suite treatment pathway for stroke patients
July 20, 2023
First Patients in France and the USA Enrolled in Global WE-TRUST Trial to Accelerate Stroke Diagnosis and Treatment
July 20, 2023 — The first patients in France and the USA have been enrolled into the large-scale WE-TRUST* multicenter…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now